✦ LIBER ✦

VKORC1 genetic polymorphism and risk of venous thromboembolism in postmenopausal women: new findings and meta-analysis

✍ Scribed by C. VERSTUYFT; M. CANONICO; E. BOUAZIZ; A. GUIOCHON-MANTEL; P.-Y. SCARABIN; FOR THE ESTROGEN AND THROMBOEMBOLISM RISK (ESTHER) STUDY GROUP

Book ID: 109152897
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 122 KB
Volume: 7
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2009.03343.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of NFE2L2 Genetic Polymorphism on

Effect of NFE2L2 Genetic Polymorphism on the Association Between Oral Estrogen Therapy and the Risk of Venous Thromboembolism in Postmenopausal Women

✍ Bouligand, J; Cabaret, O; Canonico, M; Verstuyft, C; Dubert, L; Becquemont, L; G 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

Genetic variation at the estrogen recept

Genetic variation at the estrogen receptor α locus in relation to venous thromboembolism risk among postmenopausal women

✍ C. STRACZEK; M. ALHENC-GELAS; M. L. AUBRY; P.-Y SCARABIN; THE ESTROGEN AND THROM 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Genetic polymorphism ofXRCC3Thr241Met an

Genetic polymorphism ofXRCC3Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies

✍ Sang-Ah Lee; Kyoung-Mu Lee; Sue Kyung Park; Ji-Yeob Choi; Bongcheol Kim; Jinwu N 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 164 KB

Residual vein obstruction to predict the

Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis

✍ M. CARRIER; M. A. RODGER; P. S. WELLS; M. RIGHINI; G. LE GAL 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Do adjuvant aromatase inhibitors increas

Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer : Meta-analysis of randomized trials

✍ Federica Cuppone; Emilio Bria; Sunil Verma; Kathleen I. Pritchard; Sonal Gandhi; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract ## BACKGROUND. Despite the advantages from using aromatase inhibitors (AIs) compared with tamoxifen for early breast cancer, an unexpectedly greater number of grade 3 and 4 cardiovascular events (CVAE) (as defined by National Cancer Institute of Canada‐Common Toxicity Criteria [version